95% CI, 0.84-2.23), 2.6 years for 1-year gap and tail periods (HR, 1.04
Proper lyophilization and labeling: Clearly labeled vials designated for research use only
CDSCO flags GLP-1 obesity campaigns Compliance requirements The ministry further requires all manufacturers, importers, and marketing authorization holders to ensure strict compliance with the Drugs and Cosmetics Act, 1940 and Rules made thereunder
However, individuals with a personal history of medullary thyroid carcinoma or MEN2 should avoid these medications, and those with a family history should consult with a specialist before proceeding
However, if the medication was frozen or exposed to excessive heat, it should be discarded immediately as potency cannot be guaranteed